{"id":"https://openalex.org/W2552695032","doi":"https://doi.org/10.1182/blood.v120.21.3624.3624","title":"Phase II Trial of WT1 Analog Peptide Vaccine in Patients with Acute Myeloid Leukemia (AML) in Complete Remission (CR)","display_name":"Phase II Trial of WT1 Analog Peptide Vaccine in Patients with Acute Myeloid Leukemia (AML) in Complete Remission (CR)","publication_year":2012,"publication_date":"2012-11-16","ids":{"openalex":"https://openalex.org/W2552695032","doi":"https://doi.org/10.1182/blood.v120.21.3624.3624","mag":"2552695032"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v120.21.3624.3624","doi":"https://doi.org/10.1182/blood.v120.21.3624.3624","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.3624.3624","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044188379","display_name":"Todd Louis Rosenblat","orcid":"https://orcid.org/0000-0002-9769-4832","observed_orcids":["https://orcid.org/0000-0002-9769-4832"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd L. Rosenblat","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110103402","display_name":"Mark G. Frattini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark G. Frattini","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062753493","display_name":"Suzanne M. Chanel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Suzanne M. Chanel","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062508226","display_name":"Tao Dao","orcid":"https://orcid.org/0000-0001-9937-6283","observed_orcids":["https://orcid.org/0000-0001-9937-6283"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Tao Dao","raw_affiliation_strings":["Sloan-Kettering Institute, New York, NY,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sloan-Kettering Institute, New York, NY,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010957292","display_name":"Yvette J Bernal","orcid":"https://orcid.org/0000-0002-8763-5935","observed_orcids":["https://orcid.org/0000-0002-8763-5935"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yvette Bernal","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055703943","display_name":"Joseph Gerard Jurcic","orcid":"https://orcid.org/0000-0002-1671-9998","observed_orcids":["https://orcid.org/0000-0002-1671-9998"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph G. Jurcic","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058656598","display_name":"Rhong Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Rhong Zhang","raw_affiliation_strings":["Sloan-Kettering Institute, New York, NY,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sloan-Kettering Institute, New York, NY,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007751991","display_name":"Pamela Simancek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Pamela Simancek","raw_affiliation_strings":["Sloan-Kettering Institute, New York, NY,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sloan-Kettering Institute, New York, NY,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001124933","display_name":"Martin S. Tallman","orcid":"https://orcid.org/0000-0002-4367-6102","observed_orcids":["https://orcid.org/0000-0002-4367-6102"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin S Tallman","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006680533","display_name":"David A. Scheinberg","orcid":"https://orcid.org/0000-0002-4160-923X","observed_orcids":["https://orcid.org/0000-0002-4160-923X","https://orcid.org/0009-0009-0651-7389"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Scheinberg","raw_affiliation_strings":["Molecular Pharmacology and Chemistry, Memorial Sloan Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology and Chemistry, Memorial Sloan Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077735185","display_name":"Peter George Maslak","orcid":"https://orcid.org/0000-0003-1949-5819","observed_orcids":["https://orcid.org/0000-0003-1949-5819"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter G. Maslak","raw_affiliation_strings":["Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5007751991","https://openalex.org/A5010957292","https://openalex.org/A5058656598","https://openalex.org/A5062508226","https://openalex.org/A5062753493"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.1327,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.51487502,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"120","issue":"21","first_page":"3624","last_page":"3624"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8949999809265137,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.09210000187158585,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/wt1-peptide-vaccine","display_name":"WT1 peptide vaccine","score":0.7940000295639038},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9739999771118164},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.9850000143051147},{"id":"https://openalex.org/keywords/wt1-antigen","display_name":"WT1 antigen","score":0.6899999976158142},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6259999871253967},{"id":"https://openalex.org/keywords/peptide-vaccine","display_name":"peptide vaccine","score":0.4410000145435333},{"id":"https://openalex.org/keywords/montanide","display_name":"Montanide","score":0.671999990940094},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.8450000286102295},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.6850000023841858},{"id":"https://openalex.org/keywords/cd4-t-cell-responses","display_name":"CD4+ T cell responses","score":0.8659999966621399},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.550000011920929},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.6119999885559082},{"id":"https://openalex.org/keywords/hla-a-02","display_name":"HLA-A*02","score":0.6970000267028809},{"id":"https://openalex.org/keywords/interferon-gamma-release","display_name":"interferon-gamma release","score":0.6000000238418579},{"id":"https://openalex.org/keywords/cytogenetic-subtypes","display_name":"cytogenetic subtypes","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7403126358985901},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.6903678774833679},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.571582555770874},{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.5703591108322144},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.4950067400932312},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4885652959346771},{"id":"https://openalex.org/C2776789287","wikidata":"https://www.wikidata.org/wiki/Q7166532","display_name":"Peptide vaccine","level":4,"score":0.48286038637161255},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.43982818722724915},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4336654841899872},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.42831581830978394},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4126625955104828},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3402162790298462},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.26802313327789307},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v120.21.3624.3624","doi":"https://doi.org/10.1182/blood.v120.21.3624.3624","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.3624.3624","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2891796311","https://openalex.org/W2482135287","https://openalex.org/W2560775546","https://openalex.org/W2276237281","https://openalex.org/W2580900718","https://openalex.org/W1558724806","https://openalex.org/W1992343552","https://openalex.org/W2027857664","https://openalex.org/W2148301776","https://openalex.org/W133233993"],"abstract_inverted_index":{"Abstract":[0,1],"3624":[2],"WT1":[3,40,89,102,148,381,414,426],"is":[4,71,384,394,399],"a":[5,19,38,63,283,324],"transcription":[6],"factor":[7],"which":[8,68,280],"has":[9,15,258,366,389],"been":[10,16,178,367],"implicated":[11],"in":[12,35,67,76,347,369],"leukemogenesis":[13],"and":[14,43,55,79,100,110,126,147,157,239,262,299,302,388,396,421,433],"used":[17],"as":[18],"marker":[20],"of":[21,31,57,97,223,252,255,304,310,329,339,351,373],"minimal":[22],"residual":[23],"disease":[24,159,360],"(MRD).":[25],"We":[26],"previously":[27],"demonstrated":[28],"the":[29,53,69,106,181,197,228,288,305,311,330,380],"feasibility":[30],"vaccinating":[32],"AML":[33,74],"patients":[34,75,87,176,199,232,247,257,292,313,335],"CR":[36,78,210],"with":[37,105,163,271,342],"multivalent":[39],"peptide":[41,149,382],"vaccine":[42,70,95,383],"inducing":[44],"immune":[45,107],"responses.":[46],"In":[47],"an":[48,259],"effort":[49],"to":[50,73,165,180,206,226,265,327,423,435],"further":[51,397],"explore":[52],"safety":[54],"efficacy":[56],"this":[58,370],"approach,":[59],"we":[60],"are":[61,248],"conducting":[62],"Phase":[64],"II":[65],"study":[66,182,198],"administered":[72,104,169],"first":[77,229],"who":[80,153,314],"completed":[81,243],"all":[82],"planned":[83],"postremission":[84],"chemotherapy.":[85],"Eligible":[86],"had":[88,315],"transcript":[90],"detectable":[91],"by":[92,135,419,431],"RT-PCR.":[93],"The":[94,203],"consisted":[96],"4":[98],"native":[99],"derived":[101],"peptides":[103,331],"adjuvants":[108],"Montanide":[109],"GM-CSF.":[111],"Patients":[112,152],"received":[113,234],"6":[114,166,237,278],"vaccinations":[115,168,279],"over":[116],"10":[117],"weeks.":[118],"Early":[119],"toxicity":[120,340],"was":[121,211,219,263],"assessed":[122],"at":[123,132,235],"weeks":[124],"2":[125,240,303],"4.":[127],"Immune":[128],"responses":[129],"were":[130,154,356],"evaluated":[131],"week":[133],"12":[134,175,244],"CD4+":[136,325],"T":[137,141,268],"cell":[138,142],"proliferation,":[139],"CD3+":[140],"interferon-g":[143],"interferon":[144],"release":[145],"(ELISPOT)":[146],"tetramer":[150],"staining.":[151],"clinically":[155],"stable":[156],"without":[158,250],"recurrence":[160],"could":[161],"continue":[162],"up":[164],"more":[167],"approximately":[170],"every":[171],"month.":[172],"To":[173],"date,":[174],"have":[177,233,242,266,307],"accrued":[179],"(6-M,":[183],"6-F;":[184],"median":[185,204,359],"age":[186],"\u2013":[187],"66":[188],"years,":[189],"range":[190],"26\u201373":[191],"years).":[192],"Cytogenetic":[193],"subtypes":[194],"varied":[195],"among":[196],"(Favorable-3,":[200],"Intermediate-5,":[201],"Unfavorable-4).":[202],"time":[205],"vaccination":[207,295,337],"after":[208,287],"achieving":[209],"7.5":[212],"months":[213],"(range:":[214],"3\u201322":[215],"months).":[216],"One":[217,254],"patient":[218],"removed":[220],"early":[221],"because":[222,338],"relapse":[224],"prior":[225],"receiving":[227],"vaccination.":[230,290],"Four":[231],"least":[236],"vaccines":[238],"others":[241],"vaccinations.":[245],"Eight":[246],"alive":[249],"evidence":[251],"disease.":[253],"these":[256],"HLA-A02":[260],"subtype":[261],"found":[264],"developed":[267],"cells":[269],"reactive":[270],"WT1-A":[272],"(native":[273],"peptide)":[274],"HLA":[275],"tetramers":[276],"following":[277],"persisted":[281],"(at":[282],"lower":[284],"level)":[285],"until":[286],"12th":[289],"Three":[291],"relapsed":[293,312],"during":[294],"(after":[296],"1,":[297],"5":[298],"11":[300],"vaccines)":[301],"3":[306],"died.":[308],"Two":[309,333],"sample":[316],"available":[317],"for":[318],"immunologic":[319,390],"evaluation,":[320],"did":[321],"not":[322],"develop":[323],"response":[326],"any":[328,402],"tested.":[332],"other":[334],"discontinued":[336],"(hypersensitivity/pain":[341],"GM-CSF":[343],"administration).":[344],"Both":[345],"remain":[346],"CR.":[348],"No":[349],"episodes":[350],"anaphylaxis":[352],"or":[353],"generalized":[354],"urticaria":[355],"observed.":[357],"Neither":[358],"free":[361],"survival":[362,365],"nor":[363],"overall":[364],"reached":[368],"small":[371],"cohort":[372],"patients.":[374],"These":[375],"preliminary":[376],"findings":[377],"demonstrate":[378],"that":[379],"relatively":[385],"well":[386],"tolerated":[387],"activity.":[391],"Trial":[392],"accrual":[393],"ongoing":[395],"follow-up":[398],"required":[400],"before":[401],"beneficial":[403],"effect":[404],"on":[405],"outcome":[406],"can":[407],"be":[408],"determined.":[409],"Disclosures:":[410],"Scheinberg:":[411],"Formula":[412,424,436],"Pharma:":[413],"Vaccine":[415,427],"inventor,":[416,428],"Patent":[417,429],"held":[418,430],"MSKCC":[420,432],"Licensed":[422,434],"Pharma,":[425],"Pharma":[437],"Patents":[438],"&":[439],"Royalties.":[440]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-11-30T00:00:00"}